Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1979 Apr;38(2):122-7.
doi: 10.1136/ard.38.2.122.

Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes

Clinical Trial

Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes

L A Runge et al. Ann Rheum Dis. 1979 Apr.

Abstract

We treated 29 rheumatoid arthritis patients with levamisole. on the basis of a 25% improvement in any 3 of 6 measurements 95% of the patients had a favourable response within 20 weeks. However, 64% of the patients discontinued levamisole by 40 to 60 weeks because of rash or secondary treatment failures. Delayed skin reactivity to streptokinase-streptodornase increased significantly in the entire treatment group, but there was in inverse correlation between skin test enhancement and clinical response. There was no overall change in lymphocytes response to phytohaemagglutinin (PHA) after 4 and 16 weeks of treatment, but seven patients with enhanced lymphocyte responsiveness to PHA experienced an earlier clinical response to levamisole. Treatment with levamisole frequently results in clinical improvement in rheumatoid arthritis, but this is not clearly related to a stimulatory effect on cell-mediated immunity. Its long-term usefulness may be limited by a high incidence of relapse and rash.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Exp Immunol. 1976 Nov;26(2):295-301 - PubMed
    1. Lancet. 1977 Apr 23;1(8017):904-5 - PubMed
    1. J Reticuloendothel Soc. 1977 Mar;21(3):175-221 - PubMed
    1. Arthritis Rheum. 1977 Nov-Dec;20(8):1445-8 - PubMed
    1. Clin Exp Immunol. 1977 Feb;27(2):313-8 - PubMed

Publication types